Teledermatological Follow-Up Consultations in Individual Prevention of Occupational Dermatoses: A Monocentric Feasibility Study on Quality and Satisfaction by Patients and Physicians.
dermatosis
occupational
skin disease
teledermatology
telemedicine
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
14 06 2023
14 06 2023
Historique:
received:
07
03
2023
revised:
05
05
2023
accepted:
09
06
2023
medline:
29
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
Teledermatology has become very popular, and not only due to the SARS-CoV-2 pandemic. Patients with occupational skin diseases (OSDs) could also benefit from teledermatology services as part of their follow-up care, but the opportunities and challenges for patients and dermatologists, especially regarding quality and satisfaction, need exploration. In this single-center feasibility study, 215 patients taking part in a tertiary prevention program for OSD were invited to participate. After obtaining consent, a follow-up video consultation appointment with the center's dermatologists was made. Quality and satisfaction with the consultations were evaluated by fully standardized online questionnaires filled in by the patients and dermatologists. A total of 68 teledermatological follow-up consultations were conducted by 10 dermatologists on 42 patients. Half of the dermatologists (50.0%) and 87.6% of the patients were satisfied with the video consultations. However, the lack of physical examination seems to be a problem, especially from the physicians' point of view (75.8%). A total of 66.1% of the dermatologists and 87.5% of the patients saw video consultations as useful supplements to face-to-face consultations. The results of our feasibility study indicate general satisfaction of patients and physicians with teledermatological sessions in occupational dermatology, especially as a useful supplement to face-to-face consultation.
Identifiants
pubmed: 37372714
pii: ijerph20126127
doi: 10.3390/ijerph20126127
pmc: PMC10298698
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Am Med Inform Assoc. 2006 Nov-Dec;13(6):660-7
pubmed: 16929036
J Dtsch Dermatol Ges. 2020 Aug;18(8):841-847
pubmed: 32881258
Postepy Dermatol Alergol. 2020 Apr;37(2):159-167
pubmed: 32489348
Arch Dermatol Res. 2021 Nov;313(9):769-772
pubmed: 33403572
J Eur Acad Dermatol Venereol. 2018 Feb;32(2):215-224
pubmed: 28516492
Dermatologie (Heidelb). 2022 Nov;73(11):853-858
pubmed: 36127464
Telemed J E Health. 2019 Nov;25(11):1022-1032
pubmed: 30741608
JAMA Dermatol. 2021 May 1;157(5):595-597
pubmed: 33787839
Dermatol Clin. 2021 Oct;39(4):599-608
pubmed: 34556249
J Dtsch Dermatol Ges. 2021 Dec 21;:
pubmed: 34932269
Clin Exp Dermatol. 2020 Aug;45(6):691-698
pubmed: 32031275
Int J Dermatol. 2006 Mar;45(3):220-9
pubmed: 16533219
J Telemed Telecare. 2017 Feb;23(2):233-238
pubmed: 26940796
J Dtsch Dermatol Ges. 2018 Aug;16(8):969-974
pubmed: 29998596
Clin Exp Dermatol. 2022 Oct;47(10):1863-1864
pubmed: 35656801
J Dtsch Dermatol Ges. 2009 Feb;7(2):122-6
pubmed: 18759737
J Dermatol. 2021 May;48(5):620-624
pubmed: 33715181
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e662-e663
pubmed: 32534472
Contact Dermatitis. 2012 Mar;66(3):140-7
pubmed: 22070197
J Telemed Telecare. 1999;5(1):55-61
pubmed: 10505370
JAAD Int. 2021 Dec;5:54-64
pubmed: 34368789
J Dermatolog Treat. 2022 Mar;33(2):910-915
pubmed: 32602763
Cureus. 2021 Mar 5;13(3):e13710
pubmed: 33824842
J Dtsch Dermatol Ges. 2018 Jul;16 Suppl 5:6-57
pubmed: 29998512
Int J Clin Pract. 2021 Dec;75(12):e15000
pubmed: 34714575
Contact Dermatitis. 2022 Sep;87(3):241-246
pubmed: 35357722
J Clin Med. 2022 Mar 10;11(6):
pubmed: 35329838